|
|
|
09:00
|
Introduction
- Prof.
John Olivier Prior Dr
Thierry Stora
(CERN)
|
|
09:30
|
Lessons learned from recent targeted radiotherapy treatments
-
Thierry Stora
(CERN)
John Olivier Prior
(until 12:00)
|
|
09:30
|
Small molecule inhibitors for tumor imaging and therapy
- Prof.
Uwe Haberkorn
(University of Heidelberg)
|
|
10:00
|
--- Coffee break ---
|
|
10:30
|
Augmented and individualized radionuclide treatment (advances in PRRT / PRLT with a clinical focus on PSMA targeted radioligand therapy)
- Prof.
Samer Ezziddin
(Saarland University Hospital, Homburg)
|
|
11:00
|
Role of THIK-1 in glioblastoma multiforme progression
- Mrs
Ioanna Prionisti
(Unige, HUG)
|
|
11:20
|
High resolution preclinical and humanTotal body molecular imaging as companion tools for theranostics
-
Stefaan Vandenberghe
(Ghent university, Belgium)
|
|
11:40
|
Determination of precision nuclear decay data for the decay of 153Gd
-
Robert Shearman
(National Physical Laboratory)
|
|
|
09:00
|
Ovarian cancer (PARTII)
-Prof.
Clemens Decristoforo
(Department of Nuclear Medicine, Medical University Innsbruck) Prof.
Samer Ezziddin
(Saarland University Hospital, Homburg)
(until 11:35)
|
|
09:00
|
Preclinical development of folate receptor-targeted radiopharmaceuticals for ovarian cancer
- Ms
Francesca Borgna
(1Center for Radiopharmaceutical Sciences, Paul Scherrer Institute, Switzerland)
|
|
09:30
|
Preclinical development with Nanobodies with a focus on ovarian cancer
- Prof.
Vicky Caveliers
(UZ Brussel - VUB)
|
|
10:00
|
Quantified nuclear medicine imaging of theranostic 155Tb
- Dr
Jill L. Wevrett
(The National Physical Laboratory, Royal Surrey County Hospital)
Karl Johnston
(CERN) Mr
Andrew Fenwick
(The National Physical Laboratory) Dr
Christopher Oldfield
(The Christie NHS Foundation Trust, The University of Manchester)
Ben Pietras
(University of Manchester) Ms
Sophia Pells
(University of Manchester (GB), National Physical Laboratory (GB))
Simon Thomas Stegemann
(KU Leuven)
Thomas Elias Cocolios
(KU Leuven - IKS) Ms
Emma Page
(The University of Manchester, The Christie NHS Foundation Trust) Mr
Ben Webster
(The National Physical Laboratory, University of Surrey) Dr
John Keightley
(The National Physical Laboratory)
Ulli Koester
(Institut Laue-Langevin (FR))
Juliana Schell
(Institut Fur Materialwissenschaft Universität Duisburg-Essen (D) Dr
Peter Ivanov
(The National Physical Laboratory) Ms
Kelley Ferreira
(andrew.fenwick@npl.co.uk) Dr
Ana Denis-Bacelar
(The National Physical Laboratory) Mr
Emlyn Price
(The University of Manchester, The Christie NHS Foundation Trust) Dr
Ben Russell
(The National Physical Laboratory) Mr
Kristof Dockx
(KU Leuven (BE)) Dr
Jill Tipping
(The Christie NHS Foundation Trust) Dr
Nick Calvert
(The Christie NHS Foundation Trust,) Dr
Sean Collins
(The National Physical Laboratory) Dr
Kerttuli Helariutta
(University of Helsinki) Dr
David Hamilton
(The Christie NHS Foundation Trust)
Ellen Helen Ulrika Jakobsson
(Helsinki Institute of Physics (FI))
|
|
10:20
|
--- Coffee break ---
|
|
10:35
|
A Novel Fluorescent Fatty Acid Probe for Non-invasive Imaging of Tumors in Living Animals
- Dr
Grigory Karateev
(EPFL)
|
|
10:55
|
Ba-131 derived Cs-131 in evaluation of the radiobiological effects of internalized Auger-electron emitters.
-
Nina Pil Fredericia
(Hevesy Laboratory, DTU-Nutech, Technical University of Denmark, Roskilde, Denmark)
|
|
11:15
|
A novel dual-imaging probe for the detection of progressive ovarian cancer
- Ms
Alexandra Litvinenko
(UNIGE) Ms
Andrea Grotzky
(UNIGE)
|
|
11:35
|
Radioisotope beams in hadron therapy
-
Claus Schmitzer
(MedAustron)
(until 12:15)
|
|
11:35
|
Simultaneous cancer treatment and online imaging with radioactive ion beams at FAIR
- Prof.
Marco Durante
(1GSI Helmholtzzentrum für Schwerionenforschung, Biophysics Department, Darmstadt, Germany)
|
|
|
09:00
|
Radioisotope beams in hadron therapy
-
Philippe Lambin
(Maastricht University)
Marco Giuseppe Pullia
(Fondazione CNAO (IT))
(until 12:00)
|
|
09:00
|
Use of radioactive ions in therapy
- Dr
Atsushi Kitagawa
(National Institutes for Quantum and Radiological Science and Technology )
|
|
09:30
|
Beams of the “lightest radionuclide useful for hadron therapy”: neutron beams for BNCT
- Dr
Ulli Köster
(Institut Laue Langevin)
|
|
09:50
|
Technical Design Report for a Carbon-11 Treatment Facility
-
Liviu Penescu
(Abstract Landscapes)
|
|
10:10
|
First step for PET aided hadrontherapy.
- Mr
KyungDon Choi
(CNAO)
|
|
10:30
|
--- Coffee break ---
|
|
11:00
|
Production of intense mass separated $^{11}$C beams for PET-aided hadron therapy
-
Simon Thomas Stegemann
(KU Leuven)
|
|
11:20
|
Charge breeding investigations for a future 11C treatment facility
- Ms
Johanna Pitters
(Institute for Isotope Research, University of Vienna.)
|
|
|
09:00
|
Accelerator techniques for medical isotope production
-
Klaus Wendt
(Johannes Gutenberg Universitaet Mainz (DE))
Alexander Gottberg
(TRIUMF (CA))
(until 12:30)
|
|
09:00
|
IBA accelerators for medical radio-isotope production
- Dr
Jarno Van de Walle
(Ion Beam Applications)
|
|
09:30
|
The MEDICIS facility – first operation year, current and future plans
-
Joao Pedro Ramos
(KU Leuven (BE))
|
|
09:50
|
The ISOLPHARM project at LNL: Production method of high specific activity radionuclides as radiopharmaceutical precursors
- Dr
Alberto Andrighetto
(INFN Laboratori di Legnaro)
|
|
10:10
|
Time-of-Flight study of molecular beams extracted from the ISOLDE RFQ cooler and buncher
-
Annie Ringvall Moberg
(Gothenburg University (SE))
|
|
10:30
|
Highly enriched target material for the production of radiopharmaceutical isotopes: the use of electromagnetic separation
-
Charles-Olivier Bacri
(CNRS)
|
|
10:50
|
--- Coffee break ---
|
|
11:20
|
Comparison of adequate LINAC acceleration techniques for e- and light ions
-
Ulrich Ratzinger
(Goethe-Universitaet Frankfurt)
|
|
11:50
|
Characterization and optimization of a versatile laser and electron-impact ion source for radioactive ion beam production at ISOLDE and MEDICIS
-
Yisel Martinez Palenzuela
|
|
12:10
|
Production of actinium-225 at JRC Karlsruhe
- Dr
Alban Kellerbauer
(European Commission, Joint Research Center (JRC))
|
|
|
09:00
|
Devices and Engineering for Radioisotopes Handling
-
Keith Kershaw
(CERN)
(until 10:50)
|
|
09:00
|
The Unites Stated Department of Energy Continues to Play a Key Role in Isotope Production by Making Significant Upgrades to its Facilities and Expanding its Collaborations
- Ms
Cathy Cutler
(BNL,Collider Accelerator Department)
|
|
09:30
|
TARGETS DEVELOPMENT AT CERN: MEDICIS LARGE CONTAINER
- Mr
Vasileios Samothrakis
(Ministere des affaires etrangeres et europeennes (FR))
|
|
09:50
|
Production of Classical and Theranostics Radionuclides
-
Moazam Mehmood Khan
(Pakistan Atomic Energy Commission (PK))
|
|
10:10
|
γ-MRI: new imaging technology with hyperpolarised radiotracers
-
Lina Pallada
(CERN)
|
|
10:30
|
Oxidation of uranium carbide targets at ISOLDE and radiochemistry infrastructures for the production of medical isotopes at MEDICIS
- Mr
Nhat-Tan Vuong
(CERN, EPFL)
|
|
10:50
|
--- Coffee break ---
|
|
11:20
|
MEDICIS-Promed Award/Graduation
-
Thierry Stora
(CERN)
Thomas Elias Cocolios
(KU Leuven - IKS)
(until 13:00)
|
|
|
17:00
|
Registration
(until 19:00)
|
|
19:00
|
Lecture on « Molecular imaging and immunotherapy in patients with cancer »
-Prof.
Elisabeth de VRIES
(BNL, Groningen, NL)
(until 19:45)
|
|
20:00
|
--- Dinner ---
|
|
22:00
|
Welcome Reception
(until 23:30)
|
|
|
12:00
|
--- LUNCH ---
|
|
13:30
|
Ovarian cancer (PART I)
-Prof.
Uwe Haberkorn
(University of Heidelberg) Prof.
Clemens Decristoforo
(Department of Nuclear Medicine, Medical University Innsbruck)
(until 16:30)
|
|
13:30
|
Ovarian cancer: Diagnosis and Systemic Treatment
- Dr
Anita Wolfer
(CHUV, Lausanne)
|
|
14:00
|
Targeting ovarian cancer with anti-MISR2 radiolabelled antibodies
- Dr
Emmanuel Deshayes
(INSERM, U1194, IRCM, Montpellier, France)
|
|
14:30
|
Comparison between microPET-based and biodistribution-based dosimetry of a 152Tb-labelled antibody in tumour-bearing mice
- Dr
Francesco Cicone
|
|
14:50
|
Towards the labelling of heat-sensitive biomolecules with terbium radionuclides: Chelation studies of DOTA-NHS with natural Tb and 161Tb
-
Irwin Cassells
(KU Leuven Association)
|
|
15:10
|
--- Coffee break ---
|
|
15:40
|
Development of 213Bi-labelled somatostatin analogues: Finding the optimal match between radiometal and chelator
- Mr
Stephen Ahenkorah
(SCK•CEN, Belgian Nuclear Research Centre, Institute for Health, Environment and Safety, Radiochemistry Unit, Mol, Belgium; SCK•CEN, Belgian Nuclear Research Centre, Institute for Health, Environment and Safety, Radiobiology Unit, Mol, Belgium; Radiopharmaceutical Research, Department of Pharmacy and Pharmacology, KU Leuven, Leuven, Belgium.)
|
|
16:00
|
Clickable Radioimmunoconjugates: Theranostic Agents for TEM1 Pre-Targeting
- Ms
Alice D'Onofrio
(Centro de Ciências e Tecnologias Nucleares, Instituto Superior Técnico, Universidade de Lisboa)
|
|
16:30
|
Kick-off Meeting: European Network of Facilities for medical isotopes by mass separation
-
Thierry Stora
(CERN)
Paul Rene Michel Lecoq
(until 19:30)
|
|
16:30
|
Welcome
-
Thierry Stora
(CERN)
|
|
16:35
|
Presentation from the European Association of Nuclear Medicine (EANM)
- Prof.
Clemens Decristoforo
(University of Innsbruk)
|
|
16:55
|
Presentation from the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA)
- Mr
Mumun Gencoglu
(Ifpma)
|
|
17:15
|
Presentation from the International Atomic Energy Agency (IAEA).
- Prof.
Amirrezza Jalilian
(IAEA)
|
|
17:35
|
INFRA-2-2020 call: Proposal preparation
-
Thierry Stora
(CERN)
Kirsten Leufgen
(SCIPROM)
|
|
17:55
|
Other Contributions
|
|
|
12:30
|
--- LUNCH ---
|
|
14:30
|
--- Excursion to Segesta Temple and Marsala salt pans ---
|
|
18:00
|
--- Apero-Dinner at Mamma Caura ---
|
|
|
12:00
|
--- Lunch ---
|
|
13:30
|
Methods for production of novel radioisotopes for theranostics
-
CATHY CUTLER
(Brookhaven National Laboratory)
Ulli Koester
(Institut Laue-Langevin (FR))
(until 17:00)
|
|
13:30
|
How versatile a cyclotron is for isotope production
- Prof.
Ferid Haddad
(GIP Arronax)
|
|
14:00
|
Isotope Harvesting at FRIB
- Prof.
Gregory Severin
(Facility for Rare Isotope Beams, Michigan State University, East Lansing, MI, USA)
|
|
14:30
|
Use of electrodeposition for the production of Tb-149
-
Thomas Sounalet
(cnrs)
|
|
14:50
|
Target concepts for the ISOLPHARM project
-
Michele Ballan
(INFN - National Institute for Nuclear Physics)
|
|
15:10
|
Extraction chromatography method for the separation of 155Tb from radionuclide impurities for primary standardisation, nuclear data measurements and SPECT imaging
- Dr
Peter Ivanov
(NPL)
|
|
15:30
|
--- Coffee break ---
|
|
16:00
|
HSA Er-169 production at ILL nuclear reactor and CERN-MEDICIS
- Dr
Roberto Formento Cavaier
(Advanced Accelerator Applications)
|
|
16:20
|
Laser-enhanced aerodynamic isotope separation for making medical radio-isotopes
- Prof.
Vandenbergh Hubert
(EPFL)
|
|
16:40
|
The chemical vapour deposition (CVD) of graphene
-
Marina Nazarova
(University of Manchester)
|
|
17:00
|
Posters Session
(until 18:30)
|
|
17:00
|
Uranium Carbide Target Development
- Prof.
António Gonçalves
(Professor)
|
|
17:10
|
ACCRA : Automatisme & Contrôle Commande Radiochimie, a software for an automated radiometals separation.
-
Isidro Da Silva
(CEMHTI, CNRS, Univ. Orléans)
Louis Frealle
(CEMHTI, Univ. Orléans)
|
|
17:20
|
POLYAZA-MACROCYCLES WITH HANGING SULFIDE SIDE-ARMS: NOVEL POTENTIAL CHELATORS FOR 111Ag
- Ms
Marianna Tosato
(Dept. of Chemical Sciences, University of Padua (Italy) and INFN-LNL (National Institute for Nuclear Physics - National Laboratory of Legnaro))
|
|
17:26
|
Orthogonal Click Chemistry for Synthesis of Dual-targeting Agents Towards αvβ3 Integrin and Folate Receptors for Molecular Imaging
- Mrs
Piriya Kaeopookum
(Dept. Nuclear Medicine, Medical University Innsbruck)
|
|
17:32
|
Clicklabe Bombesin Antagonists for Prostate Cancer Theranostics
- Dr
Antonio Paulo
(Centro de Ciências e Tecnologias Nucleares, Instituto Superior Técnico, Universidade de Lisboa)
|
|
17:40
|
Multifunctional Gold Nanoparticles as Nanoseeds for Targeted Chemoradiotherapy of Glioblastoma Multiforme (GBM)
- Mrs
Alice D'Onofrio
(Centro de Ciências e Tecnologias Nucleares, Instituto Superior Técnico, Universidade de Lisboa)
|
|
17:46
|
Production of Ac-225 at CERN-ISOLDE and prospects for CERN-MEDICIS
- Mr
Kristof Dockx
(KU Leuven (BE))
|
|
17:52
|
The isolation of terbium isotopes from matrix and isobaric impurities using extraction chromatography techniques
- Mr
Ben Webster
(The National Physical Laboratory, University of Surrey)
|
|
17:58
|
Advanced High Field Superconducting Cyclotron for Medical Isotopes Productions
- Dr
Alrashdi Ayash
(Director of the National Accelerator Technology center at KACST)
|
|
18:04
|
CiSCoTe : Cible Solide Irradiée Contrôlée en Température (Solid Target irradiated under control temperature by thermocouple and pyrometer)
-
Louis Frealle
(CEMHTI, CNRS, Univ. Orléans)
|
|
18:10
|
Isotope Production at European Spallation Source – A potential new access to neutrons
-
Yongjoong Lee
(Target Division, European Spallation Source (ESS) ERIC, Sweden )
|
|
18:16
|
Production of High Intensity 11C Beams for PET-aided Hadron Therapy
-
Simon Thomas Stegemann
(KU Leuven)
|
|
18:00
|
MEDICIS-Promed Supervisory Board Meeting
(until 19:30)
|
|
20:15
|
Supervisory Board Working Dinner
(until 22:15)
|
|
|
12:30
|
--- Lunch ---
|
|
14:00
|
Devices and Engineering for Radioisotopes Handling
-
Ferid Haddad
(Arronax)
(until 15:30)
|
|
14:00
|
Integrated Remote Handling System Development for MEDICIS
-
Keith Kershaw
(CERN)
|
|
14:30
|
Pushing the frontier of medical isotope production at TRIUMF
-
Alexander Gottberg
(TRIUMF)
|
|
14:50
|
Automated Laser Ion Source System for Production of Medical Radioisotopes
-
Vadim Gadelshin
(Johannes Gutenberg University of Mainz)
|
|
15:10
|
COST-EFFECTIVE DESIGN STRATEGIES FOR A TYPE B CONTAINER BASED ON NUMERICAL CALCULATIONS: THE COLIBRI-30
-
Maddalena Maietta
(LEMER PAX/Subatech)
|
|
15:30
|
Dragons' Den Presentations
-
Thomas Elias Cocolios
(KU Leuven - IKS) Ms
Fiona Reid
(until 18:00)
|
|
15:30
|
--- Coffee break ---
|
|
20:00
|
--- Social Dinner and Dragon's Den Award ---
|
|
|
